Brief: Cyxone Gets Approval To Start Phase 2 Study With Rabeximod In COVID-19 Patients
08/12/2020 13:48
Dec 8 (Reuters) - Cyxone AB CYXO.ST :
* RECEIVES REGULATORY APPROVAL TO INITIATE A CLINICAL PHASE 2 STUDY WITH RABEXIMOD IN
COVID-19
PATIENTS
* PRELIMINARY RESULTS ARE EXPECTED IN Q3 OF 2021
Source text for Eikon: ID:nWkr2hZdwp
Further company coverage: CYXO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))